ResearchVEGF
Genentech Biooncology

VEGF: significant throughout breast tumor development

VEGF is expressed throughout the tumor life cycle

VEGF is expressed throughout the tumor life cycle
In women presenting with a first diagnosis of breast cancer, approximately 60% of the tumors express only VEGF. However, breast cancers in some patients may express up to 6 angiogenic proteins.6

Adapted from Folkman 2005.

While many pro-angiogenic factors have been identified in breast cancer, vascular endothelial growth factor (VEGF) appears to be the only factor expressed throughout the entire life cycle of a breast tumor.6 The clinical significance of this finding is unknown.


Next section

VEGF and MVD

View references
for this site section